Common Diabetes Drug Januvia May Contain Traces of Carcinogen, FDA Says
FRIDAY, Aug. 12, 2022– The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administration...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer & Oncology | Diabetes | Endocrinology | Food and Drug Administration (FDA) | General Medicine | Januvia